Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 217 results for "Zohydro"

Pernix Introduces Zohydro ER with BeadTek

Pernix Therapeutics Holdings, a specialty pharmaceutical company, reported that the new formulation of Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules, CII, with BeadTek is now available in U.S. pharmacies. According to a release, on ..., 2 months ago

9 images for Zohydro

Citybizlist, 2 months ago
Guru Focus, 3 months ago, 3 months ago
Pharmaceutical Manufacturing Magazine, 3 months ago
Pharmaceutical Manufacturing Magazine, 3 months ago
Consumer Reports, 3 months ago
Business Insurance, 5 months ago
HCPLive, 5 months ago
Seeking Alpha, 5 months ago

New Zohydro ER Formulation with Abuse-Deterrent Technology Launched

Share this article: Pernix announced the launch of a new formulation of Zohydro ER (hydrocodone bitartrate extended-release capsules) with BeadTek, a new abuse-deterrent technology. The new formulation included BeadTek, which is an ...
 Monthly Prescribing Reference2 months ago Pernix Launches Zohydro┬« ER with BeadTek  World Energy Source2 months ago PERNIX THERAPEUTICS : Releases Pharmacokinetic Data for ZX007 Third Generation Zohydro ER on Track  4 Traders2 months ago Pernix Releases Pharmacokinetic Data for ZX007  Stockwatch2 months ago

OxyContin sales put Purdue's Sackler family on Forbes rich list

'; if(pArray.length >= 4) { i=2; } else if(pArray.length >= 3) { i=2; inline = ''; } else if(pArray.length >= 2) { i=1; inline = ''; } else if(pArray.length === 1) { i=0; inline = ''; } $('#librarydrawer_story_container script').each(function() { ...
 FiercePharma9 hours ago

Zogenix Receives $2.80 Average Target Price from Analysts (NASDAQ:ZGNX)

Shares of Zogenix (NASDAQ:ZGNX) have earned an average rating of Buy from the seven brokerages that are currently covering the company, Market Beat Ratings reports . Two analysts have rated the stock with a hold recommendation and four have given a ...
 SleekMoney10 hours ago Zogenix Given Average Recommendation of Buy by Analysts (NASDAQ:ZGNX)  American Banking News1 month ago

Today's Weak On High Volume Stock: Zogenix (ZGNX)

Reddit Email Reprint Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Trade-Ideas LLC identified Zogenix ( ...
 TheStreet.com4 days ago Zogenix (ZGNX) Flagged As Strong On High Volume  TheStreet.com1 week ago Strong On High Volume: Zogenix (ZGNX)  TheStreet.com1 month ago

Short Interest in Zogenix Decreases By 7.8% (ZGNX)

Zogenix (NASDAQ:ZGNX) saw a large decrease in short interest in the month of June. As of June 15th, there was short interest totalling 24,167,771 shares, a decrease of 7.8% from the May 29th total of 26,225,089 shares, MarketBeat.Com reports. Based ...
 SleekMoney5 days ago Zogenix Short Interest Down 5.1% in April (ZGNX)  American Banking News1 month ago

This Week In Pharma: Controversies And Revelations About Synergy And Zogenix

Jun. 25, 2015 4:50 PM ET | About: Zogenix, Inc. (ZGNX), SGYP, Includes: AGN, GWPH, IRWD by: Joe McCann Summary In my new column I will present my questions on 2 hot biotech stocks. Based on your votes, I'll interview an expert and post the ...
 Seeking Alpha1 week ago Zogenix Provides Corporate Update and Reports First Quarter 2015 Financial Results  Wall Street Select1 month ago ZOGENIX : Provides Corporate Update and Reports First Quarter 2015 Financial Results  4 Traders1 month ago

Collegium Expands Commercial Organization

Collegium Pharmaceutical, Inc. has named Barry Duke as executive vice president and chief commercial officer. In addition to Mr. Duke, Mary Ogle joined as vice president of marketing and Timothy Hermes as vice president of government affairs and ...
 Contract Pharma3 weeks ago COLLEGIUM PHARMACEUTICAL : Expands Commercial Organization With Key Appointments  4 Traders1 month ago
Malay Mail

Experts still worry despite abuse-deterrent painkillers

Anthony DiTullio would pop a painkiller in his mouth, but not just swallow it, as intended. He would chew it for 30 minutes, grinding through its protective coating and waxy unpleasantness, because the only pain he was treating was addiction. The ...
 Taipei Times Online4 weeks ago Making painkillers resistant to abuse still worry experts  Malay Mail4 weeks ago
Motley Fool

Why Zogenix, Inc. Shares Rocketed 22% Higher in May

So what: According to a press release issued by Zogenix on May 27, a low-dose of fenfluramine, a drug previously used as an anti-obesity drug, demonstrated impressive efficacy in a five-year, 12-patient study that focused on treating a rare form of ...
 Motley Fool1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less